Predictor | Graves’ disease patients | TMNG patients | ||||
---|---|---|---|---|---|---|
p-value | HR | 95% HR CI | p-value | HR | 95% HR CI | |
Age [years] | 0.102 | 1.05 | 1.013 – 1.066 | 0.195 | 1.02 | 0.98–1.05 |
Thyroid volume [ml] | 0.19 | 1.025 | 1.004 – 1.029 | 0.174 | 1.01 | 0.99–1.02 |
Iodine uptake [%] | 0.49 | 0.975 | 0.94 – 0.99 | 0.229 | 0.97 | 0.94–1.01 |
fT3 concentration at presentation | 0.84 | 1.051 | 0.83 – 1.26 | 0.947 | 0.99 | 0.78–1.26 |
Gender | 0.6 | 1.75 | 0.49 – 1.86 | 0.734 | 0.88 | 0.42–1.83 |
Tyrostatic drugs taken 2 weeks before therapy | 0.73 | 1.7 | 0.32 – 1.54 | 0.511 | 0.75 | 0.32–1.75 |